Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Index funds generally provide more control over allocations than target date funds, which automate drift. This intro explains what that means in practice.
28,480 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
In a chaotic but decisive session, the CLARITY Act survived chaotic senate moves and cleared the Senate Banking Commi...
Oracle plunges after earnings, amplifying a sell-off in cloud software as the company unveils a $40 billion capital r...
Energy refuses quit: stocks are steering a broad market rally, with the Energy Select Sector SPDR Fund powering highe...
In March, following Buffett’s long-term approach, consider two stalwart names with durable moats and steady cash flow...
A Houston geothermal startup storms Wall Street, delivering the clean energy sector’s largest IPO to date with a $10B...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
Iran launched drone and missile strikes against Bahrain and Kuwait, raising fears that peace talks could collapse. Ma...
AMD has delivered a dramatic rally this year, but the big question remains: is the move sustainable? This article bre...
A simple, durable approach to building income: three passive income ETFs worth holding for the long haul. Learn how t...
The voting tech firm Smartmatic has filed to dismiss a money laundering indictment, arguing political pressure shaped...
Strategy adds 535 BTC for roughly $43 million, expanding a monumental on-balance-asset position. The total stake now ...